Showing results (491-500 of 715) with videos related to

Sort By:
Pageof 72
Nature Communications|October 24, 2017
Induction of synthetic lethality in IDH1-mutated gliomas through inhibition of Bcl-xLGeorg Karpel-Massler, Chiaki Tsuge Ishida, Elena Bianchetti, et al.
Anticancer Research|December 22, 1998
Growth inhibition induced by Ro 31-8220 and calphostin C in human glioblastoma cell lines is associated with apoptosis and inhibition of CDC2 kinaseM Begemann, S A Kashimawo, R M Lunn, et al.
Molecular Cancer Therapeutics|January 8, 2010
Astrocyte elevated gene-1: a novel target for human glioma therapyLuni Emdad, Devanand Sarkar, Seok-Geun Lee, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|January 24, 2012
Convection enhanced drug delivery of BDNF through a microcannula in a rodent model to strengthen connectivity of a peripheral motor nerve bridge model to bypass spinal cord injuryW Martin Bauknight, Samit Chakrabarty, Brian Y Hwang, et al.
Clinical and Experimental Rheumatology|October 18, 2012
Treat-to-target in systemic lupus erythematosus: where are we today?Marta Mosca, Dimitrios T Boumpas, Ian N Bruce, et al.
The Journal of Rheumatology|September 3, 2010
The LupusQoL and associations with demographics and clinical measurements in patients with systemic lupus erythematosusKathleen McElhone, Madhura Castelino, Janice Abbott, et al.
Medgenmed : Medscape General Medicine|March 19, 2005
Pilomyxoid astrocytoma: a reviewRicardo J Komotar, J Mocco, Benjamin S Carson, et al.
Annals of the Rheumatic Diseases|March 26, 2022
Anifrolumab efficacy and safety by type I interferon gene signature and clinical subgroups in patients with SLE: post hoc analysis of pooled data from two phase III trialsEdward M Vital, Joan T Merrill, Eric F Morand, et al.
Lab on a Chip|March 4, 2026
Dissociable perfusion chip (DPC): perfusable microfluidic chip for single-cell screening of anti-cancer drugs in live glioblastoma explantsDarragh G Kennedy, Wenting Zhao, Terry L Chern, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|December 30, 2025
Efficacy and Safety of Subcutaneous Anifrolumab in Systemic Lupus Erythematosus: the Randomized, Phase 3, TULIP-SC StudySusan Manzi, Ian N Bruce, Eric F Morand, et al.
Pageof 72